Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
Conditions
Interventions
Intervention1: nil: nil
Sponsors
nil
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patient willing to give written informed consent for study. 2)Patients of both sex and age above 18 years. 3)Patients having topical steroid damaged perineum and peri-perineal area presenting
Exclusion criteria
Exclusion criteria: 1)Age less than 18 years. 2)Patients not meeting the clinical criteria for topical steroid damage. 3)Individuals with other pre-existing dermatological conditions like cushing syndrome affecting the perineum and peri-perineal area. 4)Patients unwilling or unable to provide informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To estimate Hospital based prevalence of patients with topical steroids damaged the perineum and peri-perineal area within a hospital setting. 2.To study the severity of the clinical presentation in individuals with topical corticosteroid (TCS)-induced damage to the perineum and peri-perineal area. according physician global assessment 3.To study the epidemiological and demographical profile of patients with TCS-induced damaged to the perineum and peri-perineal area 4.To assess the spectrum of the microbiological profile, including patterns and progression, in patients with TCS-induced damaged of the perineum and peri-perineal area. Timepoint: It is a cross sectional single visit study on day 0 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Determine various factor which are responsible for the topical steroid misuse in perineum and peri-perineal area 2)To determine the correlation between various demographical and clinical and microbiological profile In topical corticosteroid damaged perineum and peri-perneal area. Timepoint: It is a cross sectional single visit study on day 0 | — |
Countries
India
Contacts
Public ContactDr Nayan H Patel
GCS Medical College Hospital and Research Centre
Outcome results
None listed